Physician profile
Anant Kumar
NPI 1528051018
$31,511.70
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $4,345 · 2021: $3,600 · 2022: $2,664.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovis Surgical Technologies, INC. | $20,903.77 | 2019 | |
| Kyocera Medical Technologies, INC. | $10,323.50 | 2020-2022 | |
| Djo, LLC | $175.10 | 2022 | |
| Depuy Synthes Sales INC. | $81.73 | 2021 | |
| Radius Health, INC. | $27.60 | 2021-2022 |
6 companies reported research payments only; those appear in the research section below.
Research and ownership
$712,889.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anant Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.